Skip to main content
SpringerLink
Log in

Association between variants in the genes for leptin, leptin receptor, and proopiomelanocortin with chronic heart failure in the Czech population

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Patients with chronic heart failure (CHF) express enhanced catabolic metabolism finally resulting in overall weight loss, whereas adipokines might play a crucial role in signaling among tissues. The aim of this study was to investigate the possible associations of defined variability in leptin (dbSNP ID rs7799039), proopiomelanocortin (dbSNP ID rs3754860 and dbSNP ID rs1009388), and leptin receptor gene (dbSNP rs1137101) with CHF and evaluate their potential as the CHF susceptibility genes. The case-control study comprised a total of 372 patients of Caucasian origin with chronic heart failure (New York Heart Association [NYHA] functional classes II–IV, ejection fraction (EF) <40%) and 407 healthy controls. They were genotyped for the leptin (LEP) −2548 G/A, leptin receptor (LEPR) Gln223Arg, and proopiomelanocortin (POMC) RsaI (5′-untranslated region) and C1032G variants (intron 1) using PCR-based methodology. No case-control differences in genotype as well as allele frequencies were observed between CHF patients and controls. We constructed POMC RsaI/C1032G haplotypes, having found no significant association with body mass index (BMI), left ventricle ejection fraction (LVEF), left ventricle hypertrophy (LVH) and diabetes mellitus (DM). Multivariate regression analyses revealed an approximately 2-fold risk for NYHA class IV associated with the LEPR Gln223Arg (P = 0.0000001, odds ratio [OR] = 2.10, 95% confidence interval [CI] = 1.56−2.84); it also displayed an independent prediction role for LVEF in heart failure cases of all etiologies (P = 0.002, OR = 4.05, 95% CI = 1.36−10.06). In subanalyses according to CHF etiology the LEPR Gln223Arg showed an independent prediction role for NYHA IV in IHD patients (P = 0.0001, OR = 2.50, 95% CI = 1.69−3.82) and both for NYHA IV(P = 0.007, OR = 2.04, 95% CI = 1.20−3.84) and LVEF (P = 0.004, OR = 11.87, 95% CI = 2.08−55.6) in DCMP patients. The role of the polymorphic variants in the genes encoding for adipokines as potential CHF susceptibility genes is unclear. Based on our findings, the LEPR Gln223Arg polymorphism could be considered a disease susceptibility modulating factor both in ischemic heart disease or dilated cardiomyopathy patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clark AL, Poole-Wilson PA, Coats AJ (1996) Exercise limitation in chronic heart failure: The central role for periphery. J Am Coll Cardiol 28:1092–1102

    Article  PubMed  CAS  Google Scholar 

  2. Soderberg S, Stegmayr B, Ahlbeck-Glader C, Slunga-Birgander L, Ahren B, Olsson T (2003) High leptin levels are associated with stroke. Cerebrovasc Dis 15:63–69

    PubMed  Google Scholar 

  3. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T (1999) Leptin is associated with increased risk of myocardial infarction. J Intern Med 246:409–418

    Article  PubMed  CAS  Google Scholar 

  4. Soderberg S, Ahren B, Stegmayr B, Johnson O, Wiklund PG, Weinehall L, Hallmans G, Olsson T (1999) Leptin is a risk marker for first-ever hemorrhagic stroke in a population based cohort. Stroke 30:328–337

    PubMed  CAS  Google Scholar 

  5. Soderberg S, Olsson T, Eliasson M, Johnson O, Ahren B (1999) Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 245:533–543

    Article  PubMed  CAS  Google Scholar 

  6. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI (1997) Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270–278

    Article  PubMed  CAS  Google Scholar 

  7. Schulze PC, Kratzsch J (2005) Leptin as a new diagnostic tool in chronic heart failure. Clin Chim Acta 362(1–2):1–11

    Article  PubMed  CAS  Google Scholar 

  8. Piatti P, Di Mario C, Monti LD, Fragasso G, Sgura F, Caumo A, Setola E, Lucotti P, Galluccio E, Ronchi C, Origgi A, Zavaroni I, Margonato A, Colombo A (2003) Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 108:2074–2081

    Article  PubMed  CAS  Google Scholar 

  9. Matsui H, Motooka M, Koike H, Inoue M, Iwasaki T, Suzuki T, Kurabayashi M, Yokoyama T (2007) Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sci 80(7):672–680

    Article  PubMed  CAS  Google Scholar 

  10. Mammes O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F (2000) Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Gen 64(Pt 5): 391–394

    Article  CAS  Google Scholar 

  11. Guízar-Mendoza JM, Amador-Licona N, Flores-Martínez SE, López-Cardona MG, Ahuatzin-Trémary R, Sánchez-Corona J (2005) Association analysis of the Gln223Arg polymorphism in the human leptin receptor gene, and traits related to obesity in Mexican adolescents. J Hum Hypertens 19(5):341–346

    Article  PubMed  Google Scholar 

  12. Lu H, Duanmu Z, Houck C, Jen KL, Buison A, Dunbar JC (1998) Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res Bull 47(4):331–335

    Article  PubMed  CAS  Google Scholar 

  13. Dunbar JC, Lu H (2000) Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides 21(2):211–217

    Article  PubMed  CAS  Google Scholar 

  14. Saunders WS, Thornhill JA (1986) Pressor, tachycardic and behavioral excitatory responses in conscious rats following ICV administration of ACTH and CRF are blocked by naloxone pretreatment. Peptides 7(4):597–601

    Article  PubMed  CAS  Google Scholar 

  15. Bachelard H, Pitre M (1995) Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats. Br J Pharmacol 115(4):613–621

    PubMed  CAS  Google Scholar 

  16. Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, Vaillant E, Lorentz N, Basdevant A, Clement K, Guy-Grand B, Froguel P (1998) A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 20(3): 304–308

    Article  PubMed  CAS  Google Scholar 

  17. Rotimi CN, Comuzzie AG, Lowe WL, Luke A, Blangero J, Cooper RS (1999) The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes 48(3): 643–644

    Article  PubMed  CAS  Google Scholar 

  18. Yamaoka-Tojo M, Tojo T, Shioi T, Masuda T, Inomata T, Izumi T (2006) Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med 45(7):429–434

    Article  PubMed  Google Scholar 

  19. Chen Y, Snieder H, Wang X, Kaviya B, McCaffrey C, Spector TD, Carter ND, O’Dell SD (2005) Proopiomelanocortin gene variants are associated with serum leptin and body fat in a normal female population. Eur J Hum Genet 13(6):772–780

    Article  PubMed  Google Scholar 

  20. Baker M, Gaukrodger N, Mayosi BM, Imrie H, Farrall M, Watkins H, Connell JM, Avery PJ, Keavney B (2005) Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study. Diabetes 54(8):2492–2496

    Article  PubMed  CAS  Google Scholar 

  21. Echwald SM, Sorensen TD, Sorensen TI, Tybjaerg-Hansen A, Andersen T, Chung WK, Leibel RL, Pedersen O (1997) Amino acid variants in the human leptin receptor: lack of association to juvenile onset obesity. Biochem Biophys Res Commun 233(1): 248–252

    Article  PubMed  CAS  Google Scholar 

  22. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989

    Article  PubMed  CAS  Google Scholar 

  23. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169

    Article  PubMed  CAS  Google Scholar 

  24. Quanto: Gauderman WJ (2002) Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155: 478–484

    Article  PubMed  Google Scholar 

  25. Cowburn PJ, Cleland JG, Coats AJ, Komajda M. (1998) Risk stratification in chronic heart failure. Eur Heart J 19:696–710

    Article  PubMed  CAS  Google Scholar 

  26. Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F, Porcu M, Scherillo M, Opasich C, Di Lenarda A, Senni M, Maggioni AP (2002) Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 143:45–55

    Article  PubMed  Google Scholar 

  27. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC (2004) Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43:1439–1444

    Article  PubMed  Google Scholar 

  28. Bienertová-Vasků JA, Hlinomaz O, Vasků A (2007) Are common leptin promoter polymorphisms associated with restenosis after coronary stenting? Heart Vessels 22(5)310–315

    Article  PubMed  Google Scholar 

  29. Matsuoka N, Ogawa Y, Hosoda K, Matsuda J, Masuzaki H, Miyawaki T, Azuma N, Natsui K, Nishimura H, Yoshimasa Y, Nishi S, Thompson DB, Nakao K (1997) Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia 40:1204–1210

    Article  PubMed  CAS  Google Scholar 

  30. van Rossum CT, Hoebee B, Seidell JC, Bouchard C, van Baak MA, de Groot CP, Chagnon M, de Graaf C, Saris WH (2002). Genetic factors as predictors of weight gain in young adult Dutch men and women. Int J Obes Relat Metab Disord 26(4):517–528

    Article  PubMed  Google Scholar 

  31. Chagnon YC, Wilmore JH, Borecki IB, Gagnon J, Perusse L, Chagnon M, Collier GR, Leon AS, Skinner JS, Rao DC, Bouchard C (2000) Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab 85:29–34

    Article  PubMed  CAS  Google Scholar 

  32. van der Vleuten GM, Kluijtmans LA, Hijmans A, Blom HJ, Stalenhoef AF, de Graaf J (2006) The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia. Int J Obes 30(6):892–898

    Article  Google Scholar 

  33. White DW, Wang DW, Chua SC Jr, Morgenstern JP, Leibel RL, Baumann H, Tartaglia LA (1997) Constitutive and impaired signalling of leptin receptors containing the Gln-Pro extracellular domain fatty. Proc Natl Acad Sci USA 94:10657–10662

    Article  PubMed  CAS  Google Scholar 

  34. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 86:4434–4439

    Article  PubMed  CAS  Google Scholar 

  35. Mattevi VS, Zembrzuski VM, Hutz MH (2002) Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord 26(9):1179–1185

    Article  PubMed  CAS  Google Scholar 

  36. van Rossum CT, Hoebee B, van Baak MA, Mars M, Saris WH, Seidell JC (2003) Genetic variation in the leptin receptor gene, leptin, and weight gain in young Dutch adults. Obes Res 11(3):377–386

    Article  PubMed  Google Scholar 

  37. Mergen H, Karaaslan C, Mergen M, Deniz Ozsoy E, Ozata M (2007) LEPR, ADBR3, IRS-1 and 5-HTT genes polymorphisms do not associate with obesity. Endocr J 54(1):89–94

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic

    Julie Anna Bienertová-Vašků, Petr Bienert & Anna Vašků

  2. First Department of Internal Medicine/Cardioangiology, Faculty of Medicine and St Ann’s Faculty Hospital, Brno, Czech Republic

    Lenka Špinarová

Authors
  1. Julie Anna Bienertová-Vašků
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lenka Špinarová
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petr Bienert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Vašků
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Anna Bienertová-Vašků.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bienertová-Vašků, J.A., Špinarová, L., Bienert, P. et al. Association between variants in the genes for leptin, leptin receptor, and proopiomelanocortin with chronic heart failure in the Czech population. Heart Vessels 24, 131–137 (2009). https://doi.org/10.1007/s00380-008-1090-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-008-1090-5

Key words

Search

Navigation